Tiger Tech reported on Thursday the receipt of the first of its kind US FDA's Emergency Use Authorization for its first machine learning-based COVID screening device under the new CDC guidelines to help re-open more schools and arenas for sports.
This US FDA EUA for the company's COVID screening device was made possible with the help of Mount Sinai Medical Center Miami, Florida, the Miami Rescue Mission Homeless Clinic and the Meadows K-12 School (Las Vegas, Nevada).
The Tiger Tech COVID plus monitor is COVID screening device that is intended for use by trained personnel to help prevent exposure to and spread of SARS-CoV-2. The screening device will reportedly identify certain biomarkers to indicate COVID-19 Infection. The markers are also present in COVID asymptomatic subjects.
According to the company, the COVID Plus is an armband with embedded sensors that acquire biometric signals from the body. This device is completely noninvasive. Over a period of three to five minutes, the COVID Plus Monitor checks for abnormalities in a participant's biometrics, including COVID-19 complications. The device uses hundreds of unique biomarkers to find patterns associated with COVID-19.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project